Multilink Consortium, Liverpool School of Tropical Medicine, Malawi-Liverpool-Velkam Program, Exhibiti University of Health and Allied Sciences and Kilimanjaro Christian Medical University College have published a NIHR-funded partnership, sub-culturally for frightening, and for effects for effects. Multimorbidity refers to the presence of two or more chronic diseases.

Researchers found that four hospitals in Malawi and Tanzania were admitted to 1007 patients, 47% had multimorbidity, the highest high blood pressure, diabetes or HIV. Such conditions increase the risk of heart failure, stroke and chronic kidney disease and premature death diseases.

With a long -term position (28.3%) or no long -term position (13.5%), patients with multimorbidity were significantly more likely to die within 90 days of entering the hospital.

In a study published in Lancet Global Health, the economic cost of multimorbidity was also shown, including income loss with acute disease, poor quality of life and high medical bills, especially in Tanzania, where healthcare is not free at the point of use.

Conclusions display significant burden of multimorbidity in healthcare systems that usually do not screen for long -term conditions. This unfortunately often means that initial Diagnosis Created after complications.

Researchers argue that their findings show that multimorbidity is an essential public health threat that requires changes in health care distribution to meet the needs of the population. More research is now required to identify and control chronic illness, prevent complications, reduce disability and mortality and to test the model of reference-sensitive health systems to ensure financial security for patients.

Dr. Stephen Spencer, Welcom Trust Clinical PhD Fellow of Liverpool School of Tropical Medicine and Malawi-Liverpool-Velkam Program (MLW), and co-first author on paper, said: “Multimorbidity sub-collecting is a growing problem in Africa, such as non-circulatory (such as Hives and TB) Hydroelectric (such as Hives and TB) Hyperstitious, Hydroely, Hydroely. Diseases like heart disease, and we see multimorbidity in older adults along with young adults.

“When a person comes to the hospital with a person uncontrolled or uncontrolled multimorbidity, we have the opportunity to detect and treat all the conditions that they can suffer, but this resource is a challenge in limited hospitals that are already subject to stress. The way of care of the hospital also focuses on a single -presenting disease, which also focuses on the risk of prevention and dancing. Try to reduce continuously.

Professor Professor of Health Economics at LSTM and Multilink cum-Leid, Professor Eve Warol said: “I am proud of the multicolink team for the evidence presented in this paper. Not only does it highlight some important challenges faced by people living with multimbidity, and it is a clear form that it is a clear form, but it is a clear form to work in a clear form, but it is a clear form to work. Is important.

“Paper suggests how multimorbidity is reduced in Malawi and Tanzania, which probably affects the cost of the health system, the patient’s cost and health quality of life, and leads to the rescueable mortality. Given that many people living with multimorbidity are working, which are beyond the health sector, which are the health sector, which are the multimidity. The next phase of the multilinking study will detect the viability of strategies to achieve this. “

Malawi’s health system, as with most health systems in sub-city Africa, is currently overwhelmed by treating the burden of a couple of communicable and non-communicable diseases. Recent research findings states that there are many long -term conditions in about half of the medical entry, there is an additional stress for the system. Preparing our health system to identify and treat multimorbidity should be a priority. ,

Dr. Felix Limbani, Co-Facilitation Investigator, Multilink and MLW

The paper also included Achikondi Women’s Community Clinic at Queen Elizabeth Central Hospital, Kamuju University of Health Sciences and Malawi, Kilimanjaro Clinical Research Institute in Tanzania, Manchester University in UK and Duke University School of Medicine in the United States.